Using Ad-Hoc Reports For Mid-Study Monitoring

Challenge and Background Monitoring study progress and safety of subjects are critical factors to a study’s success. The most effective way to stay informed of the current status of these factors is to utilize a constant mid-study monitoring process. Even with the use...

VISION Supported Xeris Pharmaceuticals in Diabetes Drug Research

Austin, Texas – Xeris Pharmaceuticals recently announced the completion of its Series B stock offering which will allow the commercialization of their newest Diabetes Injectable Drug offerings. The funding will be used to promote their G-Pen (a glucagon injectable)....

Introducing VISION™ 9

AUSTIN, TX – December 15, 2016 – Prelude Dynamics announces its release of VISION™ 9. VISION™ is Prelude’s Clinical Trial Optimization Platform that goes beyond EDC. The launch of VISION™ 9 has generated much excitement. It’s new features...
Page 4 of 9« First...23456...Last »